Orexigen and Patheon enter into exclusive manufacturing agreement for Contrave March 16, 2010 No Comments
Ipsen grants Rhythm worldwide license for two programs in metabolic disorders March 15, 2010 No Comments
BioInvent and Human Genome Sciences enter collaboration for monoclonal antibodies March 12, 2010 No Comments
Affymax receives milestone payment from Takeda for phase III Hematide trial in Japan March 11, 2010 No Comments
Transgene signs exclusive option agreement with Novartis for NSCLC therapeutic TG-4010 March 11, 2010 No Comments
Cellzome and GSK enter strategic drug discovery alliance in inflammatory disease March 11, 2010 No Comments
RSS